This finding introduced the pivotal concept that therapeutic strategies could be designed to manipulate cell death mechanisms, specifically by promoting autophagy in dying cells, to ensure HMGB1 release, thereby stimulating an adaptive immune response that could seek out and destroy residual tumor cells, ultimately improving long-term treatment efficacy [113]. This evidence concerns the gene HMGB1 and neoplasm.